Johnson & Johnson (NYSE: JNJ) today announced first results from Cohort 4 of the Phase 2b SunRISe-1 study evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with certain ...

Medtronic (NYSE:MDT) announced today that it recently submitted its Hugo surgical robot platform to the FDA for a urologic ...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced that the Expand URO Investigational Device ...

Medtronic , a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption ...